
NeuroGenesis Inc. Stock Analysis NEUN
NeuroGenesis, Inc. manufactures and markets nutritional supplements of a particular type. The company is headquartered in League City, Texas. The company went IPO on 2001-10-05. The Company’s products include Neu-Becalm'd 90 Capsules and Neu-Relieve 90 Capsules. The Company’s nutritional supplements are manufactured and packaged in one of its two facilities located across the United States.
Read More NeuroGenesis Inc (NEUN) Chart
Key Statistics of NeuroGenesis Inc (NEUN)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
-P/E Ratio (TTM)
-52 Week Range
Market Cap
8226.20Avg. Volume
-Dividend Yield
-Financial Metrics & Statements of NeuroGenesis Inc (NEUN)
FAQ's for NeuroGenesis Inc (NEUN)
- According to Musaffa’s Shariah screening methodology, NeuroGenesis Inc (NEUN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.